activation of human insulin by vitamin e: a molecular
TRANSCRIPT
Accepted Manuscript
Activation of human insulin by vitamin E: A molecular dynamics simulation study
Hossein Soleymani, Mohammad Ghorbani, Abdollah Allahverdi, SeyedehsamanehShojaeilangari, Hossein Naderi-manesh
PII: S1093-3263(19)30129-9
DOI: https://doi.org/10.1016/j.jmgm.2019.06.006
Reference: JMG 7389
To appear in: Journal of Molecular Graphics and Modelling
Received Date: 3 March 2019
Revised Date: 2 June 2019
Accepted Date: 3 June 2019
Please cite this article as: H. Soleymani, M. Ghorbani, A. Allahverdi, S. Shojaeilangari, H. Naderi-manesh, Activation of human insulin by vitamin E: A molecular dynamics simulation study, Journal ofMolecular Graphics and Modelling (2019), doi: https://doi.org/10.1016/j.jmgm.2019.06.006.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service toour customers we are providing this early version of the manuscript. The manuscript will undergocopyediting, typesetting, and review of the resulting proof before it is published in its final form. Pleasenote that during the production process errors may be discovered which could affect the content, and alllegal disclaimers that apply to the journal pertain.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
1
Activation of human insulin by vitamin E: A molecular dynamics
simulation study
Hossein Soleymani1, Mohammad Ghorbani1, Abdollah Allahverdi1, Seyedehsamaneh Shojaeilangari2, and
Hossein Naderi-manesh1, 3*
1 Biophysics Department, Faculty of Biological Sciences, Tarbiat Modares University, 14115-154, Tehran, Iran
2 School of Cognitive Science, Institute for Research in Fundamental Sciences (IPM), 193955746, Tehran, Iran
3 School of Biological Science, Institute for Research in Fundamental Sciences (IPM), 19395-5746, Tehran, Iran
EMAIL:
Hossein Soleymani: [email protected]
Mohammad Ghorbani: [email protected]
Abdollah Allahverdi: [email protected]
Seyedehsamane Shojaeilangari: [email protected]
Corresponding Author: Hossein Naderi-manesh: [email protected]
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
2
Abstract:
Lack of perfect insulin signaling can lead to the insulin resistance, which is the hallmark of
diabetes mellitus. Activation of insulin and its binding to the receptor for signaling process
initiates via B-chain C-terminal hinge conformational change through an open structure to
“wide-open” conformation. Observational studies and basic scientific evidence suggest that
vitamin D and E directly and/or indirectly prevent diabetes through improving glucose
secretion and tolerance, activating calcium dependent endopeptidases and thus improving
insulin exocytosis, antioxidant effect and reducing insulin resistance. On the contrary, clinical
trials have yielded inconsistent results about the efficacy of vitamin D supplementations for
the control of glucose hemostasis. In this work, best binding modes of vitamin D3 and E on
insulin obtained from AutoDock Vina were selected for Molecular Dynamic, MD, study. The
binding energy obtained from Molecular Mechanics- Poisson Boltzman Surface Area, MM-
PBSA method, revealed that Vitamins D3 and E have good affinity to bind to the insulin and
vitamin E has higher binding energy (-46 kj/mol) by engaging more residues in binding site.
Distance and angle calculation results illustrated that vitamin E changes the B-chain
conformation and it causes the formation of wide-open/active form of insulin. Vitamin E
increases the ValB12-TyrB26 distance to ~15 Å and changes the hinge angle to ~65°.
Consequently, essential hydrophobic residues for binding to insulin receptor exposed to
surface in the presence of vitamin E. However, our data illustrated that vitamin D3 cannot
change B-chain conformation. Thus our MD simulations propose a model for insulin
activation through vitamin E interaction for therapeutic approaches.
Keywords: Insulin, Hinge opening, Diabetes mellitus, Molecular dynamics simulation, MM-
PBSA
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
3
Abbreviations:
COM, Center Of Mass; LINCS, Linear Constraint; MD, Molecular Dynamics; MM-PBSA,
Molecular Mechanics- Poisson Boltzman Surface Area; PDB, Protein Data Bank; SPC,
Simple Point Charge; PME, Particle Mesh Ewald; Rg, Gyration Radius; RMSD, Root Mean
Square Deviation; SPC water, Simple Point-charge Water; VMD, Visual Molecular
Dynamics;
Introduction:
Observational studies and basic scientific evidence suggest that vitamin D and E directly
and/or indirectly prevent diabetes through improving glucose secretion and tolerance,
activating calcium dependent endopeptidases and thus improving insulin exocytosis,
antioxidant effect and reducing insulin resistance [1-3]. It has been reported that type 2
diabetes mellitus patients are associated with vitamin D3 deficiency [4]. Recently, it has been
demonstrated that vitamin D supplementations are inversely affiliated with insulin resistance,
which may have beneficial effects on controlling several complications of childhood obesity
[5]. Vitamin D and E supplementations could diminish insulin resistance in patients with non-
insulin dependent diabetes mellitus with substantial improvements in serum fasting plasma
glucose (FPG) and insulin [6, 7]. New clinical trial on 2,423 participants has been established
that vitamin D supplementations decrease the risk of diabetes [8]. F. Cadario et. al in 2017
reported that co-administration of omega 3 fatty acid and high dose vitamin D could assist to
halt the progression of type 1 diabetes [9]. Low dairy intake of vitamin E supplementations
during the second pregnancy trimester can dwindle the risk of hyperglycemia and insulin
resistance [10].
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
4
Supernumerary evidence has strongly proposed that vitamin D plays a significant role in
amending the risk of diabetes. However, the findings of type 2 diabetes are derived
particularly from observational and basic studies, which may be missed by a variety of
parameters. Only a few and often underpowered clinical trials have been designed to test the
effectiveness of vitamin D and E administration in diabetes [11]. Many ongoing randomized
trials are trying to test the hypothesis that vitamin D and E lower type 2 diabetes risk [12].
Insulin is a peptide produced by beta cells of islets of pancreas that plays its role as one of the
main anabolic hormones in the body. It regulates the metabolism of proteins, fats, and
carbohydrates by promulgating the absorption of glucose from the blood into skeletal muscle,
fat and liver cells [13]. Investigations in the last century illustrated that insulin served a key
role in the advancement of structural biology, peptide chemistry, pharmacology and cell
signaling [14, 15].
The functional and biologically active form of insulin is a monomer comprising 51 amino
acids containing two chains, an A-chain of 21 and a B-chain of 30 residues, which are linked
together by two inter-chain disulfide bridges between CysA7-CysB7 and CysA20-CysB19. The
A-chain has an intra-chain disulfide bridge between CysA6-CysA11 as well. The A-chain has
an N-terminal helix from GlyA1 to ThrA8, continued with an antiparallel C-terminal helix from
SerA12 to CysA20. The B-chain also has two N- and C-terminal strands surrounding a central
helix GlyB8 to CysB19. This conformation is known as T conformation (Fig. 1a and b). At
micromolar concentration, insulin dimerizes through a β sheet structure of both C-terminal
portions of the B-chain, and in the higher concentrations in the presence of zinc ions
associates into the beautiful symmetrical structures of hexamer [16, 17].
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
5
Fig. 1. Structural details of the insulin molecule and vitamins D3 and E. (a) 3D structure of human insulin
(PDB ID: 2G4M). A-chain (yellow); B-chain N-terminal (residues PheB1 to GlyB8) (red), B-chain α-helix
(residues SerB9 to CysB19) (black), B-chain C-terminal (residues GlyB20 to ThrB30) (blue). The colored spheres
demonstrate the Cα atoms of the first and last residues of the A and B-chains. (b) Side chains of the insulin
hydrophobic core: GlyB8, LeuB11, ValB12, LeuB15, PheB24, TyrB26 (shown in purple), IleA2 and ValA3 (shown in
green).
The mechanism of monomeric insulin conformational changes and its engagements with the
receptor has long been still enigmatic [18]. Attentions have been recently focused on B-chain
C-terminus portion that is critical for self-assembly in β cells and receptor attachment in
target tissues. In particular, the C-terminal residues of the B-chain (nearly PheB24-ThrB30)
egresses from the helical core to divulge buried nonpolar surfaces (the detachment model)
[19]. Therefore, the C-terminal β-strand (PheB24-ThrB27) and β-turn (GlyB20-GlyB23) rotate
away from the alpha-helical core of insulin to expose its conserved aromatic motif
(PheB24,PheB25,TyrB26) to insulin receptor binding site [20]. Most recent findings showed that
opening of B-chain C-terminus is inherently stochastic and then transition through an open
structure to “wide-open” conformation. The wide-open conformation is critical for receptor
binding, however, this conformation occurs very seldom. B-chain C-terminus opens as a
zipper mechanism; also PheB24 acts as a hinge that is retained in the prevailing closed/inactive
state by neighboring TyrB26 hydrophobic effect. The TyrB26 is the essential residue for
initiation of B-chain C-terminal opening and activation of insulin [21].
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
6
Engagement of insulin to its receptor in the primary hormone binding site (α-subunit domains
L1 and α-CT) occurs due to hinge-like rotation at insulin’s GlyB20-GlyB23 β-turn, coupling
reorientation of PheB24 to a 60o rotation of the PheB25-ThrB30 away from the protein
hydrophobic core. Inauguration of this hinge exposes conserved nonpolar side chains (PheB24,
PheB25, ValB12, IleA2 and ValA3) to engage the receptor [22]. Restraining the hinge
reconstitution by nonstandard mutagenesis preserves native conformation but blocks receptor
binding [20, 23].
Different strategies have been reported to treat diabetes, such as immunomodulation [24],
metabolic/bariatric surgery [25, 26], islet transplantation [27], amino acid substitution for
insulin stability improvement [28] and ligand binding [29, 30]. In the last decade, vitamins
have scintillated more attention to diabetes treatment [31]. Vitamin D directly and/or
indirectly prevents diabetes through improving glucose secretion and tolerance, activating
calcium dependent endopeptidases and thus improving insulin exocytosis, antioxidant effect
and reducing insulin resistance [2, 32].
Phenolic components widely used for maintaining insulin preparations can have a profound
result on the insulin’s conformation in solution [33]. Phenol group stabilizes more helix
structures in the insulin hexamer [34]. This conformational change can affect the hormone’s
stability and function [35]. Vitamin E as a phenolic compound reduces oxidative stress and
protein glycosylation as well as improves insulin sensitivity and insulin action after oral
administration [7, 10]. Recently, it was found that cholecalciferol and α-tocopherol -the
active forms of vitamin D and E in blood stream in the vicinity of insulin, strongly bind to
hydrophobic patch of human insulin and change insulin’s structure and improve its stability
[36].
In the present work, we investigated the interactions between α-tocopherol and
cholecalciferol with human insulin monomer individually using molecular dynamic
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
7
simulation approach. The aim was to study the effect of vitamin binding on insulin B-chain
conformational transition, which play an important role in the insulin/insulin receptor
attachment as a critical component for insulin function.
2. Methods:
2.1. Molecular docking
In the MD simulations, we used a crystal structure of human insulin monomer with a
resolution of 1.35 Å (PDB ID: 5ENA [37]). Vitamins structures were obtained from the
Brookhaven Protein Data Bank (PDB IDs: 3C6G [38] for vitamin D3 and 3CXI [39] for
vitamin E). Molecular docking was done using AutoDock Vina with standard parameters
[40]. Both vitamins were docked to the human insulin monomer in 26 × 26 × 34 Å grid box.
Best binding structures for each vitamin were selected using the best score of AutoDock Vina
results. By analyzing the binding energy and RMSD, certain insulin-vitamin complexes were
selected for simulation studies.
2.2. MD simulations
MD simulations were performed using the Gromacs 4.6.7 package using Gromos96 53a6
force field [41, 42]. The ligands topologies were generated by the PRODRG server [43]. The
structure of insulin monomer was solvated in SPC water molecules. Na+ and Cl- ions were
placed in the solvated system to neutralize it and to set the NaCl concentration to 0.1 M. The
system was then exposed to a primary minimization of water molecules followed by
equilibration. Steepest descent energy minimization was performed down to a maximum
gradient of 1000 KJmol-1nm-1. The system was simulated in two steps, 1000 ps of position
restrained dynamics using LINCS algorithm followed by full 100 ns standard MD [44]. The
system was coupled to a Berenson’s thermostat method with the reference temperature of 300
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
8
k, further, standard pressure of 1.0 bar with a coupling constant of 1000 ps for pressure. It is
noteworthy, during this time, positions of all bonds were constrained. PME electrostatics
were applied using the Lennard-Jones cutoff of 1.4 nm and a Coulomb cutoff of 0.9 nm [45].
MD simulations were done during 100 ns for all minimized structures with time step of 2 fs.
Equilibrium of the system was monitored from the RMSD plot. Images were created using
PyMOL molecular graphic system [46], VMD [47] and the program LigPlot+ v 1.0 [48],
which generates schematic 2-D representations of protein ligand complexes from the PDB
file input [49, 50].
2.3. MM-PBSA analysis
The binding affinity of vitamins could be investigated on the basis of binding free energy.
Gibbs free energy was calculated by the procedure MM-PBSA [51, 52]. Interaction energy
for insulin with vitamin D3 and E were calculated. MM-PBSA methods were implemented
for 90 to 100 ns. For each simulated system, 1000 snapshots were taken from the last 10 ns of
the trajectory at the intervals of 10 ps. In this study, different components of interaction
energy which contribute to vitamin binding were estimated. This includes van der Waals
interactions, electrostatic interactions, polar and non-polar solvation energy. The MM-PBSA
analysis also offers a unique contribution to the binding affinity and per residue distribution
that provides significant amino acid in all cases. Energy decomposition per residues and MM-
PBSA revealed the relative importance of amino acid involved in binding and different
components of binding energy.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
9
3. Result and Discussion:
3.1. Molecular docking
The blind-docking results indicated that insulin monomer has only one binding site for
vitamins. The grid dimensions for accurate-dock were adjusted according to the binding site.
AutoDock Vina scored twenty interaction modes for each complex based on the affinity and
distance from the best mode. Best docking conformations of vitamin-insulin complexes,
generated by Autodock, were taken as initial structure for MD simulation. Table 1 shows the
binding energies of the chosen complexes. Vitamin D3 and E bind to hydrophobic groove of
insulin with the lowest binding energy of -29.7 and -36.5 kj/mol, respectively.
Interaction modes and the orientation of vitamins are also illustrated in Fig. 2. In Fig. 2, it is
shown both vitamins D3 and E are bound to hydrophobic region between two α-helix
structures in A and B-chain interface. After binding of vitamins, the B-chain C-terminal
hinge is free to couple with its receptor by formation of wide-open conformation. In other
words, vitamins do not inhibit insulin interaction with its receptor and insulin activity is
maintained. Fig. 3 shows the hydrophobic interactions between insulin and vitamins created
by LigPlot+ program in 2D representation [53]. LeuA13, TyrA14, GluA17, PheB1, GlnB4, AlaB14,
LeuB17, ValB18 and ArgB22 residues participate in hydrophobic interaction.
Table 1. Binding energy. Obtained binding energies of the molecular docking and MM-PBSA method for
vitamin D3 and vitamin E.
Insulin-Vitamin D3 Insulin-Vitamin E
Docking Binding Energy (kj/mol) -29.7 -26.8
MD Binding Energy (kj/mol) -36.5 -46
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
10
Fig. 2. The orientations of the D3 (shown in blue) (a) and vitamins E (shown in green) (b) bound to the A-
chain; Hydrophobic surface schematics of human insulin monomer interacted with vitamin D3 (c) and vitamin E
(d). Insulin is shown in hydrophobic representation.
Fig. 3. 2D plot of protein (insulin)-ligand (vitamin D3 and E) interaction (generated by LigPlot+ obtained
from docking results). Ligplot of insulin with vitamin D3 (a). Ligplot of insulin with vitamin E (b). Red
semicircle shows hydrophobic interactions.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
11
3.2. Conformational stability of insulin
MD simulation is a reliable method to find out the structural movement of molecules and
atoms as a function of time. To explore the conformational stability of insulin and effective
conformation samplings during the MD simulations, the root mean square deviation (RMSD)
was computed based on the starting structure. The RMSD method averaging all the particles
at a time. This action is based-on the comparison of the structure after the simulation with the
first structure and the smaller its numerical value, the simulated system is more stable [54].
The backbone RMSD of A and B-chain and Rg (gyration radius) of insulin-vitamin
complexes in comparison to the apo-insulin are plotted in Fig. 4 and average values are
shown in Table 2. The entire conformation of the apo-insulin structure was observed stable
about 0.12 and 0.3 nm for A and B-chain, respectively, during the simulation. The RMSD
was generally stable, however, some interesting variations occurred in B-chain insulin, which
is related to B-chain C-terminal fluctuation. In the insulin-Vitamin E simulation, the average
RMSD of B-chain was calculated about 0.5 nm (Fig. 4b). As expected, the RMSD of insulin-
Vitamin E shows persistent variation, probably because of phenol effect on the insulin
conformational changes and hinge opening [55].
The radius of gyration (Rg) was measured to examine the dynamic stability and compactness
of protein in the presence of vitamins. A time evolution plot of Rg (backbone) is shown in
Fig. 4c. Several consecutive and continuous fluctuation is seen in Rg trajectory from
beginning of simulation, which is due to major structural changes of protein. This drift in Rg
is maintained up to 50 ns. Thereafter, a constant fluctuation is seen up to 75 ns,a gain in Rg is
observed up 90 ns. The vitamin E changes the gyration radius of insulin due to its influence
on the B-chain hinge conformational transition.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
12
Fig. 4. RMSD and Gyration radius. RMSD of backbone atoms of insulin-vitamin complexes in respect to apo-
insulin for A-chain (a) and B-chain (b). Rg of whole protein with respect to 100 ns molecular dynamics
simulations (c).
Table 2. RMSD profile of protein backbone atoms and Rg profile of whole protein calculated over the course of
100 ns molecular dynamic simulations.
3.3. MM-PBSA analysis
To estimate the strength of interaction between vitamins and insulin and difference in the
binding energy between vitamins, MM-PBSA method was applied for 98 to 100 ns. The
obtained values indicated that the contribution of van der Waals interaction in the total
interaction energy was much larger than the electrostatic energy (Table 3). The positive value
of polar solvation energy indicated a little contribution to vitamin binding with insulin [56].
In order to recognize the hotspot residues of insulin ligand binding, the contribution of every
residue was explored. Per residue binding energy decomposition for insulin with both
vitamins suggested that IleA10, LeuA13, LeuA16, PheB1, GlnB4, LeuB6, AlaB14, LeuB17, ValB18
were the major residues interacting with vitamins (Fig. 5). Per residue energy contributions
Apo-Insulin Insulin-Vitamin D3 Insulin-Vitamin E
A-chain RMSD (nm) 0.12 0.14 0.13
B-chain RMSD (nm) 0.3 0.27 0.5
Rg (nm) 1.03 1.02 1.05
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
13
illustrated that the favorable binding free energy originates predominantly from the nonpolar
terms.
Table 3. Binding energy values (kj/mol) and individual component energy calculated with MM-PBSA method
for insulin with vitamin D3 and vitamin E.
Van der Waal
energy
Electrostatic
energy
Polar solvation
energy SASA energy Binding energy
Insulin-Vitamin D3 -40.413 +/- 5 -0.258 +/- 0.18 9.453 +/- 2.12 -5.233 +/- 0.65 -36.451 +/- 4.14
Insulin-Vitamin E -54.087 +/- 7.1 -0.079 +/- 0.085 14.281 +/- 2.67 -6.099 +/- 0.799 -45.984 +/- 5.41
Fig. 5. Energy decomposition graph for individual amino acid residues majorly contributing to binding
energy. IleA10, LeuA13, LeuA16, PheB1, GlnB4, LeuB6, AlaB14, LeuB17, ValB18 were the major residues interacting
with vitamin E.
3.4. Opening of B-chain C-terminal hinge
There are several strategies for investigation of B-chain C-terminal conformational changes
to study how vitamins can affect insulin structure and function. Distance computation
between B-chain C-terminal and α-helix residues and also calculating angle changes of B-
chain used for hinge conformational transition analysis. We selected three pair residues from
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
14
the B-chain C-terminal and B-chain α-helix for calculating distances of pair residues and
studying conformational changes of B-chain. GlyB8, ValB12 and LeuB15 were selected from α-
helix portion and distances were calculated from 3 C-terminal residues (PheB24 ,TyrB26
,ProB28) for all trajectories. Fig. 6a shows the distances between the Cα atoms of the three
pairs from the MD simulation. These distances provide the most useful indexes for opening
of the B-chain C-terminus portion and hence must pay more attention to it.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
15
Fig. 6. Illustration of the residue pairs for (a) distance calculation and (b) Angle computation. The spheres
represent the Cα atoms of the B-chain α-helix and B-chain C-terminal residues, respectively. (c and e) Up and
lateral view of Insulin-Vitamin E complex, and (d and f) Up and lateral view of Insulin-Vitamin D3 complex
after simulation.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
16
The MD simulation result for the vitamin apo-insulin shows that it mainly remains in the
closed conformation and the B-chain C-terminus portion makes only sporadic excursions
away from the B-chain α-helix (Fig. 7). Fig. 7 shows the stability of hinge in apo-insulin.
Distance calculation in apo-insulin hinge shows distance in all indexes remain under 8.5 Å.
Based on previous experimental and computational results, calculated distance in apo-insulin
B-chain hinge is about 10 Å, so B-chain hinge is in the closed conformation. These findings
were validated by comparing with the recently reported MD simulations by A. Papaioannou,
et al. [21] and corresponding crystal structure 2G4M. The average distances between the Cα
atoms of B-chain C-terminal and B-chain α-helix approbate with the experimental values
within 10 Å (Fig. 7). As displayed in Fig. 1b, the side chains of PheB24, PheB24 and TyrB26
participate in the formation of hydrophobic core, which play the main role of maintaining
insulin in the closed state.
GlyB8-ProB28 and ValB12-TyrB26 distances provide the most useful indicators for opening and
wide-opening of the B-chain C-terminal, respectively. There is a good confirmation between
our results and the experiments, which further validates the MD simulations. Obtained results
show the LeuB15-PheB24 distance of apo-insulin does not change, in accordance with a hinge
behavior, while others increase to varying values. Average distances between the Cα atoms of
the pairs LeuB15- PheB24, ValB12-TyrB26 and ProB28-GlyB8 are approximately 7.5, 8.3 and 6.8 Å
respectively. It is obvious from all the MD simulations that there is no systematic dynamic
behavior or opening mechanism like a switch or periodic motion between two states. The
insulin activation casually occurs at the simulated times and appears to be an accidental event
(Fig. 7).
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
17
Fig 7. Stability of the hinge. Distances between the Cα atoms of the LeuB15-PheB24, ValB12-TyrB26 and GlyB8-
ProB28 pairs, which represent at the hinge, for the apo-insulin.
Time series of the distances between Cα atoms of GlyB8-ProB28 illustrated that open
conformation of B-chain C-terminal hinge is formed affected by vitamin E (Fig. 8a). As it is
obvious from the time series of the distances between Cα atoms of ValB12-TyrB26, increasing
of distance and opening of hinge occurred only in the presence of vitamin E and hence only
vitamin E can induce the wide-open conformation, not vitamin D3 (Fig. 8b). ValB12-TyrB26
average distance increased from 0.83 Å in apo-insulin to 1.34 Å in insulin-Vitamin E that
clearly shows the wide-open conformation.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
18
Fig. 8. Time series of the distances between the Cα atoms of (a) GlyB8-ProB28 , (b) ValB12-TyrB26 and (c)
LeuB15-PheB24. These distances are used as a criterion for the opening of the B-chain hinge and activation of
insulin.
Examination of the time series of the distances of insulin hinge in insulin-Vitamin D3
complex shows that the ValB12-PheB24 and GlyB8-ProB28 distances do not change, so vitamin
D3 could not activate insulin for binding to its receptor. Distances between Cα atoms of
LeuB15-PheB24 shows B-chain hinge most stable in all simulations, illustrated the importance
of β-turn in insulin structure.
How insulin changes conformation to engage the insulin receptor has long been unclear. The
recent structural experiment of insulin and its receptor demonstrated that B-chain protective
hinge of insulin opens to initiate receptor binding procedure [20]. It explained that, on
receptor binding, B-chain C-terminal fragment undergoes reorientation of PheB24 to a 60°
rotation of the PheB25-LysB29 strand away from the insulin core, to expose buried residues to
its receptor.
The angle changes were calculated for the confirmation of distance results and
characterization of the wide-open conformation. To analysis of angle changes in B-chain C-
terminal, GlyB8, GluB21 and LysB29 were selected for structure of open conformation (PheB25-
LysB29). Since wide-open conformation occurs in the B-chain hinge (PheB24-TyrB26), GlyB8,
GluB21 and TyrB26 were selected for the computation of wide-open conformation. In Fig 9(a
and b), representative angle variation throughout the trajectories for all simulations are
shown; four Cα atoms were selected for angle calculation. The positions of these atoms
provide a good representation of the movement of the C-terminal coil relative to the α-helix
and opening of the hinge: GluB21 is situated in the center of the hinge, which is between helix
and coil structure, GlyB08 is situated at the opposite side of helix in front of the coil structure,
LysB29 is situated at the flexible end of C-terminus coil, and TyrB26 is situated in the middle of
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
19
the C-terminus coil and instantly after β-turn, which is the key residue in formation of the
wide-open conformation. Accordingly, Cα atoms of these amino acids move as the hinge
opens.
Fig. 9. Variation of the B-chain hinge angle along the MD simulation trajectories. The angles are measured
between Cα atoms of GlyB8, GluB21 and (a) LysB29, (b) TyrB26. Hydrogen bond of B-chain hinge with A-chain in
(c) apo-insulin and (d) insulin-Vitamin E.
The maximum opening for the apo-insulin in the ValB12-TyrB26 is ~8 Å (Fig. 7), while
surprisingly vitamin E increases the ValB12-TyrB26 distances to ~15 Å (Fig. 8b). The average
opening for the apo-insulin is ~20 degrees (GlyB8, GluB21 and LysB29) (Fig. 9a) and ~30
degrees (GlyB8, GluB21 and TyrB26) (Fig. 9b), while in the presence of vitamin E, the hinge
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
20
opens to ~85 and ~65 degrees, respectively. Reorientation of PheB24 to a 60o rotation of the
PheB25-ThrB30 away from the protein hydrophobic core occurs in wide-open conformation of
insulin [20]. Obtained results reveal that vitamin E bounded to A and B-chain interface
induces conformational changes in the B-chain hinge and obviously opens it.
A contact map is an exclusively useful 2D representation of aminoacid-aminoacid
interactions in protein 3D structure [57]. Intramolecular contact maps were computed as
shown in Fig. 10. The contact maps clearly show the contact changes in the presence of
vitamins. An inspection of this contact maps reveal that distances of PheB25-ThrB30 from
GlnB4-ValB18 increases in the insulin-Vitamin E complex related to the apo-insulin. As can be
clearly seen from distance and angle variation and contact map results, the wide-opening of
the B-chain hinge occurs in the presence of vitamin E. Vitamin D3 does not affect on the
Activation of insulin by hinge opening.
Fig. 10. Contact map results. Mean smallest distance for insulin in the presence of vitamins. Distances of
PheB25-ThrB30 from GlnB4-ValB18 increases in the insulin-Vitamin E complex related to the apo-insulin.
3.5. Secondary structure
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
21
Insulin forms a small helix-rich (44%) globular protein with 30% random coil, 9% β-strands
and 19% turns [58]. The Dictionary Secondary Structure of Proteins (DSSP) analysis
performed to identify the secondary structures of each insulin residue in all MD simulations
(Fig. 11). The DSSP analysis showed that the secondary structure elements are intact in the
apo-insulin (Fig. 11a). As observed in Fig. 11b, the insulin secondary structures began to lost
its helical contents mostly in 3-9 residues at the presence of vitamin D3, which is in
agreement with our previous experimental study [36]. Vitamin D3 destroys helical structure at
GlyA1-CysA8 residues, which is somewhat unstable in apo-insulin. The DSSP analysis also
revealed that vitamin E does not change the helical contents of human insulin during the MD
simulation. As it is shown in Fig. 11, β-bridges (isolated backbone hydrogen bonds) are
present in residues CysA11 and HisB5 of apo-insulin. In insulin-Vitamin D3 complex CysA11
and HisB5 β-bridges deform in the last 20 ns of simulation time. In insulin-vitamin E complex
CysA11 and HisB5 β-bridges fully deform and CysA20 and PheB24 β-bridges form, which are
stable during MD simulation. Vitamin E also destroys CysB19-ArgB22 turn structure by
disrupting hydrogen bonds between TyrA19-PheB25. It seems that TyrA19-PheB25 hydrogen
bond disruption may changethe turn structure and induces hinge conformational changes.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
22
Fig. 11. The time evolution of the secondary structure of human insulin monomer in (a) apo-insulin, (b)
insulin-Vitamin D3, and (c) insulin-Vitamin E. Per residue secondary structure density during the last 10 ns of
trajectory are shown in (d) apo-insulin, (e) insulin-Vitamin D3, and (f) insulin-Vitamin E.
Conclusion:
Vitamin D and E supplementations are conventionally used as a long-term oral intake for
diabetes treatment. In this work, for the first time, we investigated the interaction of vitamin
E and vitamin D3 with human insulin by computational insights. Our binding energy MM-
PBSA calculation results reveal that Vitamins D3 and E bind to the insulin, also vitamin E
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
23
engages to more residues and reaches high binding energy of -46 kj/mol. Our data is in
agreement with our previous experimental results [36]. Per residue energy contributions
illustrated that the favorable binding free energy originates predominantly from the nonpolar
terms. IleA10, LeuA13, LeuA16, PheB1, GlnB4, LeuB6, AlaB14, LeuB17, ValB18 were the major
residues interacting with vitamins. Distance and angle calculation results illustrated that
vitamin E changes the B-chain conformation and it causes the formation of wide-open/active
form of insulin. ValB12-TyrB26 distance provides a useful index for studying the
conformational changes and forming wide-open structure of B-chain hinge. Vitamin E
increases the ValB12-TyrB26 distance from ~8 Å in apo-insulin to ~15 Å. In addition, the hinge
angle rises to ~65° in the presence of vitamin E. Distance and angle histogram show that
wide-open conformation is most stable in insulin-Vitamin E complex. On the other hand,
vitamin D cannot change the hinge conformation, therefore, activation of insulin does not
occur in insulin-Vitamin D3 complex. The DSSP analysis revealed that insulin secondary
structure does not much change in both vitamin-insulin complexes. It seems that vitamin E
increases the helical contents of dimeric insulin, due to its phenolic structure, and it does not
lead to significant changes in the monomeric insulin helical contents.
As a result, our MD simulations propose a model for insulin activation through vitamin E
interaction for therapeutic approaches. In conclusion, these findings provide new insights on
the conformational changes of insulin B-chain hinge that is crucial to enable its binding to the
insulin receptor. Finally, we propose a new approach for activation of insulin without any
gene manipulation or mutagenesis for diabetes treatment.
Appendix A. Supplementary Data:
MD simulations repeated using the Gromacs 2019.2 package and supplementary appendix
has been written as per reviewer’s suggestion.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
24
Acknowledgement:
This research has been supported by Tarbiat Modares Research grant, IG-39708. We thank
Dr. Mehrdad Ravanshad for providing computational facility in Tarbiat Modares computer
center.
References: Uncategorized References
1. Riek, A.E., et al., Vitamin D3 supplementation decreases a unique circulating monocyte
cholesterol pool in patients with type 2 diabetes. The Journal of Steroid Biochemistry and
Molecular Biology, 2018. 177: p. 187-192.
2. Pham, T.-M., et al., The relationship of serum 25-hydroxyvitamin D and insulin resistance
among nondiabetic Canadians: a longitudinal analysis of participants of a preventive health
program. PLoS One, 2015. 10(10): p. e0141081.
3. Hochberg, I., et al., Interaction between the haptoglobin genotype and vitamin E on
cardiovascular disease in diabetes. Current Diabetes Reports, 2017. 17(6): p. 42.
4. Saha, P., et al., Patients with type 2 diabetes have reduced levels of plasma vitamin D. Asian
Journal of Medical Sciences| May-Jun, 2016. 7(3): p. 35.
5. Kelishadi, R., et al., Effects of vitamin D supplementation on insulin resistance and
cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled
trial. Jornal de Pediatria, 2014. 90(1): p. 28-34.
6. Talaei, A., M. Mohamadi, and Z. Adgi, The effect of vitamin D on insulin resistance in patients
with type 2 diabetes. Diabetology & Metabolic Syndrome, 2013. 5(1): p. 8.
7. Fang, F., Z. Kang, and C. Wong, Vitamin E tocotrienols improve insulin sensitivity through
activating peroxisome proliferator-activated receptors. Molecular Nutrition & Food
Research, 2010. 54(3): p. 345-352.
8. LeBlanc, E.S., et al., Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d)
Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts.
Diabetes Care, 2018: p. dc180240.
9. Cadario, F., et al., Can type 1 diabetes progression be halted? Possible role of high dose
vitamin D and omega 3 fatty acids. European Review for Medical & Pharmacological
Sciences, 2017. 21(7): p. 1604-1609.
10. Ley, S., et al., Lower dietary vitamin E intake during the second trimester is associated with
insulin resistance and hyperglycemia later in pregnancy. European Journal of Clinical
Nutrition, 2013. 67(11): p. 1154.
11. Maddaloni, E., et al., Vitamin D and diabetes mellitus, in Vitamin D in Clinical Medicine. 2018,
Karger Publishers. p. 161-176.
12. Mitri, J. and A.G. Pittas, Vitamin D and diabetes. Endocrinology and Metabolism Clinics,
2014. 43(1): p. 205-232.
13. Brange, J. and L. Langkjœr, Insulin structure and stability, in Stability and Characterization of
Protein and Peptide Drugs. 1993, Springer. p. 315-350.
14. Mayer, J.P., F. Zhang, and R.D. DiMarchi, Insulin structure and function. Peptide Science,
2007. 88(5): p. 687-713.
15. Boucher, J., A. Kleinridders, and C.R. Kahn, Insulin receptor signaling in normal and insulin-
resistant states. Cold Spring Harbor Perspectives in Biology, 2014. 6(1): p. a009191.
16. Frankær, C.G., et al., Insulin fibrillation: The influence and coordination of Zn2+. Journal of
Structural Biology, 2017. 199(1): p. 27-38.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
25
17. De Meyts, P., Insulin and its receptor: structure, function and evolution. Bioessays, 2004.
26(12): p. 1351-1362.
18. Haeusler, R.A., T.E. McGraw, and D. Accili, Biochemical and cellular properties of insulin
receptor signalling. Nature Reviews Molecular Cell Biology, 2018. 19(1): p. 31.
19. De Meyts, P., Insulin/receptor binding: the last piece of the puzzle? Bioessays, 2015. 37(4): p.
389-397.
20. Menting, J.G., et al., Protective hinge in insulin opens to enable its receptor engagement.
Proceedings of the National Academy of Sciences, 2014. 111(33): p. E3395-E3404.
21. Papaioannou, A., S. Kuyucak, and Z. Kuncic, Molecular dynamics simulations of insulin:
elucidating the conformational changes that enable its binding. PloS One, 2015. 10(12): p.
e0144058.
22. Menting, J.G., et al., A minimized human insulin-receptor-binding motif revealed in a Conus
geographus venom insulin. Nature Structural & Molecular Biology, 2016. 23(10): p. 916-920.
23. Zˇáková, L., et al., Structural integrity of the B24 site in human insulin is important for
hormone functionality. Journal of Biological Chemistry, 2013: p. jbc. M112. 448050.
24. Abdi, R., et al., Immunomodulation by mesenchymal stem cells: a potential therapeutic
strategy for type 1 diabetes. Diabetes, 2008. 57(7): p. 1759-1767.
25. Mingrone, G., et al., Bariatric–metabolic surgery versus conventional medical treatment in
obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre,
randomised controlled trial. The Lancet, 2015. 386(9997): p. 964-973.
26. Paoli, P., et al., The insulin-mimetic effect of Morin: a promising molecule in diabetes
treatment. Biochimica et Biophysica Acta (BBA)-General Subjects, 2013. 1830(4): p. 3102-
3111.
27. Bruni, A., et al., Islet cell transplantation for the treatment of type 1 diabetes: recent
advances and future challenges. Diabetes, Metabolic Syndrome and Obesity: Targets and
Therapy, 2014. 7: p. 211.
28. Hirsch, I.B., Insulin analogues. New England Journal of Medicine, 2005. 352(2): p. 174-183.
29. Ward, C.W. and M.C. Lawrence, Similar but different: ligand-induced activation of the insulin
and epidermal growth factor receptor families. Current Opinion in Structural Biology, 2012.
22(3): p. 360-366.
30. Xu, Q., et al., BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves
insulin resistance in C2C12 myotubes. International Journal of Biological Macromolecules,
2018. 106: P. 379-386.
31. Rochette, L., et al., Diabetes, oxidative stress and therapeutic strategies. Biochimica et
Biophysica Acta (BBA)-General Subjects, 2014. 1840(9): p. 2709-2729.
32. Saha, P., et al., Patients with type 2 diabetes have reduced levels of plasma vitamin D3 and
are well correlated with the oxidative stress parameters. Asian Journal of Medical Sciences,
2016. 7(3): p. 35-40.
33. WOLLMER, A., et al., Phenol-promoted structural transformation of insulin in solution.
Biological Chemistry Hoppe-Seyler, 1987. 368(2): p. 903-912.
34. Derewenda, U., et al., Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer.
Nature, 1989. 338(6216): p. 594.
35. Dunn, M.F., Zinc–ligand interactions modulate assembly and stability of the insulin hexamer–
a review. Biometals, 2005. 18(4): p. 295-303.
36. Soleymani, H., et al., Vitamin E induces regular structure and stability of human insulin, more
intense than vitamin D 3. International Journal of Biological Macromolecules, 2016. 93: p.
868-878.
37. Mandal, K., et al., Crystallization of Enantiomerically Pure Proteins from Quasi-Racemic
Mixtures: Structure Determination by X-Ray Diffraction of Isotope-Labeled Ester Insulin and
Human Insulin. ChemBioChem, 2016. 17(5): p. 421-425.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
26
38. Strushkevich, N., et al., Structural analysis of CYP2R1 in complex with vitamin D3. Journal of
Molecular Biology, 2008. 380(1): p. 95-106.
39. dos Santos, J.I., A.M. Soares, and M.R. Fontes, Comparative structural studies on Lys49-
phospholipases A2 from Bothrops genus reveal their myotoxic site. Journal of Structural
Biology, 2009. 167(2): p. 106-116.
40. Trott, O. and A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a
new scoring function, efficient optimization, and multithreading. Journal of Computational
Chemistry, 2010. 31(2): p. 455-461.
41. Hess, B., et al., GROMACS 4: algorithms for highly efficient, load-balanced, and scalable
molecular simulation. Journal of Chemical Theory and Computation, 2008. 4(3): p. 435-447.
42. Oostenbrink, C., et al., A biomolecular force field based on the free enthalpy of hydration and
solvation: the GROMOS force-field parameter sets 53A5 and 53A6. Journal of Computational
Chemistry, 2004. 25(13): p. 1656-1676.
43. Schüttelkopf, A.W. and D.M. Van Aalten, PRODRG: a tool for high-throughput
crystallography of protein–ligand complexes. Acta Crystallographica Section D: Biological
Crystallography, 2004. 60(8): p. 1355-1363.
44. Hess, B., et al., LINCS: a linear constraint solver for molecular simulations. Journal of
Computational Chemistry, 1997. 18(12): p. 1463-1472.
45. Darden, T., D. York, and L. Pedersen, Particle mesh Ewald: An N⋅ log (N) method for Ewald
sums in large systems. The Journal of Chemical Physics, 1993. 98(12): p. 10089-10092.
46. DeLano, W.L., The PyMOL molecular graphics system. http://www. pymol. org, 2002.
47. Humphrey, W., A. Dalke, and K. Schulten, VMD: visual molecular dynamics. Journal of
Molecular Graphics, 1996. 14(1): p. 33-38.
48. Wallace, A.C., R.A. Laskowski, and J.M. Thornton, LIGPLOT: a program to generate schematic
diagrams of protein-ligand interactions. Protein Engineering, Design and Selection, 1995.
8(2): p. 127-134.
49. Laskowski, R.A. and M.B. Swindells, LigPlot+: multiple ligand–protein interaction diagrams
for drug discovery. 2011, ACS Publications.
50. Seeliger, D. and B.L. de Groot, Ligand docking and binding site analysis with PyMOL and
Autodock/Vina. Journal of Computer-Aided Molecular Design, 2010. 24(5): p. 417-422.
51. Kumari, R., et al., g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations.
Journal of Chemical Information and Modeling, 2014. 54(7): p. 1951-1962.
52. Homeyer, N. and H. Gohlke, Extension of the free energy workflow FEW towards implicit
solvent/implicit membrane MM–PBSA calculations. Biochimica et Biophysica Acta (BBA)-
General Subjects, 2015. 1850(5): p. 972-982.
53. Gao, M. and J. Skolnick, A comprehensive survey of small-molecule binding pockets in
proteins. PLoS Computational Biology, 2013. 9(10): p. e1003302.
54. Aier, I., P.K. Varadwaj, and U. Raj, Structural insights into conformational stability of both
wild-type and mutant EZH2 receptor. Scientific Reports, 2016. 6: p. 34984.
55. Karavassili, F., et al., Structural studies of human insulin cocrystallized with phenol or
resorcinol via powder diffraction. Acta Crystallographica Section D: Biological
Crystallography, 2012. 68(12): p. 1632-1641.
56. Kumar, A., et al., Docking, molecular dynamics, binding energy-MM-PBSA studies of
naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
Journal of Biomolecular Structure and Dynamics, 2018(just-accepted): p. 1-37.
57. Toon, A. and G. Williams, A dynamical approach to contact distance based protein structure
determination. Journal of Molecular Graphics and Modelling, 2012. 32: p. 75-81.
58. Hua, Q.-x. and M.A. Weiss, Mechanism of insulin fibrillation the structure of insulin under
amyloidogenic conditions resembles a protein-folding intermediate. Journal of Biological
Chemistry, 2004. 279(20): p. 21449-21460.
MANUSCRIP
T
ACCEPTED
ACCEPTED MANUSCRIPT
Highlights:
• Imperfection of insulin signaling can lead to insulin resistance, which is the hallmark
of diabetes mellitus. Vitamin E and D3 play a crucial role in insulin sensitivity
improvement and diabetes treatment.
• Activation of insulin and binding to its receptor for signaling process initiates via B-
chain C-terminal hinge conformational change.
• The wide-open structure of B-chain hinge is critical for receptor binding. Val12-
Tyr26 distances provide the most useful indicator for wide-open conformation
• Vitamin E effectively activates human insulin monomer via B-chain hinge opening.
Val12-Tyr26 distances of apo-insulin increases from ~8.3 Å to ~13 Å and hinge angle
increases from ~30° to ~65° in the presence of vitamin E.